Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E26.79 EPS (ttm)5.57 Insider Own0.08% Shs Outstand2.63B Perf Week-1.79%
Market Cap392.41B Forward P/E15.39 EPS next Y9.69 Insider Trans-2.68% Shs Float2.63B Perf Month0.63%
Income15.12B PEG4.72 EPS next Q2.16 Inst Own70.40% Short Float0.79% Perf Quarter13.88%
Sales82.06B P/S4.78 EPS this Y7.60% Inst Trans0.54% Short Ratio3.22 Perf Half Y13.54%
Book/sh22.09 P/B6.75 EPS next Y7.17% ROA10.60% Target Price161.81 Perf Year9.36%
Cash/sh6.82 P/C21.87 EPS next 5Y5.68% ROE27.50% 52W Range126.10 - 154.50 Perf YTD2.24%
Dividend3.80 P/FCF45.45 EPS past 5Y3.10% ROI17.00% 52W High-3.47% Beta0.70
Dividend %2.55% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.60% 52W Low18.27% ATR1.69
Employees135100 Current Ratio1.30 Sales Q/Q1.90% Oper. Margin23.20% RSI (14)48.87 Volatility0.85% 1.14%
OptionableYes Debt/Eq0.49 EPS Q/Q-54.50% Profit Margin19.90% Rel Volume0.89 Prev Close150.13
ShortableYes LT Debt/Eq0.46 EarningsJan 22 BMO Payout59.60% Avg Volume6.49M Price149.14
Recom2.10 SMA20-0.83% SMA501.75% SMA2008.83% Volume7,231,010 Change-0.66%
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Feb-18-20 10:17AM  Health-care stocks hinge on presidential politics and theyre now looking favorable MarketWatch
10:00AM  Sanofi partners with U.S. agency to develop coronavirus vaccine Reuters
09:30AM  Johnson & Johnson to Expand Partnership with U.S. Department of Health & Human Services to Accelerate the Discovery of Potential COVID-19 Treatments PR Newswire
04:00AM  This entrepreneur booked 300% revenue growth in 2 years American City Business Journals
Feb-17-20 05:57PM  Pioneer Investments Buys Microsoft, Amazon, Apple GuruFocus.com
Feb-14-20 04:20PM  Dow Jones Today: A Day for Safe Havens InvestorPlace
10:19AM  Drug wholesaler stocks falls after WSJ report that states rejected opioid settlement offer MarketWatch
09:52AM  Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails Zacks
08:23AM  The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering Benzinga
Feb-13-20 04:23PM  Dow Jones Today: Coronavirus Controversy Reemerges InvestorPlace
02:25PM  3 Dow Jones Industrial Average Stocks to Sell InvestorPlace
Feb-12-20 05:16PM  Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference PR Newswire
03:48PM  China Keeps Experts Waiting; Conference Canceled: Virus Update Bloomberg
10:30AM  Buy AbbVie for its Growth Prospects, Yield and Low Valuation GuruFocus.com
09:43AM  J&J (JNJ) Signs Deal With HHS to Develop Coronavirus Vaccine Zacks
09:18AM  The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga
09:00AM  This Medical Giant Is Lingering In A Buy Zone Are Shares A Good Bet? Investor's Business Daily
08:00AM  ISRG Stock: Should You Invest In The Biggest Robotic Surgery Player? Investor's Business Daily
Feb-11-20 04:52PM  Releasing Quarantined Americans; Cruise Concerns: Virus Update Bloomberg
04:44PM  J&J partners with U.S. agency to develop coronavirus vaccine Reuters
04:30PM  Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine PR Newswire
10:00AM  JNJ Stock Continues To Hit Fresh Highs Is It Time To Buy Shares? Investor's Business Daily
09:15AM  J&J Files Application for Darzalex Label Expansion With FDA Zacks
07:23AM  The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology Benzinga
Feb-10-20 02:43PM  New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA Benzinga
07:53AM  Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar? Zacks
Feb-09-20 10:45AM  3 Compelling Stocks to Catch on Possible Recession TipRanks
Feb-07-20 04:29PM  Our Favorite Dividend ETF GuruFocus.com
04:22PM  Coronavirus update: Business impact widens as China fights to get infections under control Yahoo Finance
02:13PM  Why a Harvard professor is asking shareholders to vote away their right to sue Yahoo Finance
02:09PM  With Alibaba Stock the Waiting Is the Hardest Part InvestorPlace
02:07PM  AbbVie's (ABBV) Q4 Earnings Beat, 2020 View Solid, Stock Up Zacks
01:11PM  T. Rowe Price Keeps Buying Fox, General Electric GuruFocus.com
12:34PM  Johnson & Johnson Hit with $750M Punitive Damages Verdict for Failing to Warn about Cancer-Causing Asbestos in Talc Products PR Newswire
08:19AM  Can JNJ Stock Keep on Its Current Growth Track? InvestorPlace
08:18AM  Breaking: J&J to Pay $750M in Baby Powder Case Investing.com
07:31AM  Stocks - U.S. Futures Point Lower; Caution Sets in Ahead of Payrolls Investing.com
04:45AM  Outsmarting a Killer: Georgia inventors, researchers finding new tech to tackle heart disease American City Business Journals
Feb-06-20 05:50PM  Can Biotech ETFs Continue to Soar in 2020? Zacks
05:36PM  J&J Brand Most Valuable Among Pharmaceutical Companies GuruFocus.com
03:55PM  Jury orders Johnson & Johnson to pay $750 million in New Jersey talc case Reuters
03:36PM  J&J ordered to pay $750 mln in NJ talc case -lawyer Reuters
02:26PM  64 Best Dividend Stocks You Can Count On in 2020 Kiplinger
11:00AM  Glaxo (GSK) Lags Q4 Earnings & Revenue Estimates, Stock Down Zacks
Feb-05-20 03:19PM  FOCUS-Drugmakers see long road ahead in coronavirus vaccine race Reuters
03:00PM  WHO Says There's No Effective Coronavirus Treatment Yet Benzinga
11:17AM  Regeneron Expands Agreement to Develop Coronavirus Therapy Zacks
10:37AM  Can Humira/Cancer Drugs Help AbbVie (ABBV) Beat Q4 Earnings? Zacks
10:27AM  Theravance Pipeline Strong, Dependence on Yupelri a Concern Zacks
09:47AM  Merck (MRK) Beats on Q4 Earnings, Plans Women Health Spin Off Zacks
06:34AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Feb-04-20 01:19PM  Coronavirus update: China toll skyrockets, but markets calm amid government cash infusion Yahoo Finance
08:03AM  AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards? Zacks
01:00AM  FDA to hold public meeting on testing for asbestos in talc Reuters
Feb-03-20 06:49PM  Edited Transcript of JNJ earnings conference call or presentation 22-Jan-20 1:00pm GMT Thomson Reuters StreetEvents
01:06PM  Arrowhead (ARWR) to Report Q1 Earnings: What's in the Cards? Zacks
11:16AM  Vaxart (VXRT) to Make Vaccines to Check Coronavirus, Stock Up Zacks
06:54AM  Merck (MRK) to Report Q4 Earnings: Is a Beat in the Offing? Zacks
Feb-01-20 03:28PM  Barron's Picks And Pans: Intel, Johnson & Johnson, T-Mobile And More Benzinga
Jan-31-20 11:08AM  Johnson & Johnson Is Ordered to Pay California Over Deceptive-Marketing Claim Barrons.com
10:52AM  Some Drugmakers Are Racing to Develop a Coronavirus Vaccine. Why Big Pharma Isnt Rushing In. Barrons.com
10:32AM  Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative Zacks
07:30AM  Bayer wins EU recommendation for prostate cancer drug Reuters
07:20AM  The Wining Sector & Its Top Stocks in Virus-Infected January Zacks
12:56AM  PRESS DIGEST-New York Times business news - Jan 31 Reuters
Jan-30-20 06:21PM  J&J (JNJ) Plans to Develop Vaccine for New Coronavirus Zacks
03:40PM  Coronavirus update: US records first human-to-human transmission as WHO declares global emergency Yahoo Finance
12:10PM  Hedge Fund Hotels in 2020: Visa Inc (V) vs. Market Cap Peers Insider Monkey
10:51AM  Biogen (BIIB) Surpasses Q4 Earnings and Sales Estimates Zacks
09:43AM  Montco biopharm firm's stock surges again on new coronavirus pact American City Business Journals
09:26AM  The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance Benzinga
Jan-29-20 01:40PM  Coronavirus update: Vaccine expected in Phase 1 trial within months, WHO to reconvene on Thursday MarketWatch
12:02PM  Johnson & Johnson working on vaccine for coronavirus Reuters Videos
09:55AM  How Microsoft, PepsiCo and other solid plays helped this fund manager ride out a bumpy decade MarketWatch
09:54AM  Alkermes' (ALKS) NDA for ALKS 3831 Accepted by FDA for Review Zacks
09:04AM  J&J begins development of coronavirus vaccine MarketWatch
09:01AM  Johnson & Johnson starts developing vaccine for coronavirus Reuters
08:56AM  Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More Zacks
08:48AM  Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat PR Newswire
05:19AM  Johnson & Johnson Says It's Working on a Coronavirus Vaccine TheStreet.com
Jan-28-20 10:51AM  Johnson & Johnson Is the Quintessential Recession-Proof Company GuruFocus.com
Jan-27-20 07:01PM  UK healthcare cost agency rejects J&J's nasal spray for depression Reuters
03:43PM  J&J CEO testifies: 'I did not read all the documents' Reuters Videos
02:21PM  CDC officials say coronavirus is similar to SARS, no new U.S. cases reported MarketWatch
10:47AM  Your 6-point plan to navigating a choppy stock market MarketWatch
10:33AM  J&J CEO questioned over stock sale ahead of story on asbestos in Baby Powder Reuters
10:26AM  J&J chief testifies he did not read all documents related to asbestos in talc Reuters
09:16AM  Johnson & Johnson Is 'Confident' In Ability To Treat Coronavirus, But Vaccine Could Take Time Benzinga
09:15AM  Coronavirus Ends Weekly Winning Streaks Zacks
08:11AM  J&J CEO to testify at trial for first time on Baby Powder risks Reuters
05:54AM  J&J Confident of Development of Coronavirus Vaccine; Credit Suisse Boosts Price Target TheStreet.com
Jan-24-20 02:11PM  Johnson & Johnson Stock at Cusp of Historic Breakout Investopedia
12:24PM  Top Stock Research Reports for Intel, Boeing & Blackstone Zacks
09:54AM  Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU Zacks
09:12AM  J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children Zacks
Jan-23-20 06:00PM  Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments GuruFocus.com
11:45AM  Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy? Zacks
10:36AM  US Indexes End Mostly Flat Wednesday GuruFocus.com
06:30AM  Johnson & Johnson Sold a Hot Biotech Stock Barrons.com
Jan-22-20 04:25PM  Dow Jones Medical Giant Johnson & Johnson Slips On Mixed Quarter Investor's Business Daily
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM